Orbimed Advisors Llc - Aug 15, 2021 Form 4 Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Role
Director, 10%+ Owner
Signature
/s/ Sven H. Borho, Member of OrbiMed Advisors LLC
Stock symbol
XTNT
Transactions as of
Aug 15, 2021
Transactions value $
$0
Form type
4
Date filed
8/17/2021, 05:58 PM
Previous filing
Jul 21, 2021
Next filing
Aug 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XTNT Common Stock Other $0 +85.3K +242.35% $0.00 121K Aug 15, 2021 See Footnotes F1, F2, F3
transaction XTNT Common Stock Other $0 +85.3K +242.35% $0.00 121K Aug 15, 2021 See Footnotes F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 See Exhibit 99.1.
F2 These shares are subject to restricted stock unit awards granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan, as amended, and vest and become issuable on August 15, 2022, conditioned upon the reporting person remaining a director of Xtant through the vesting date.
F3 This report on Form 4 is jointly filed by Advisors and ROF II. Each of ROS Acquisition and ORO II disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. Advisors has designated certain representatives, including Matthew Rizzo and Michael Eggenberg, both of whom are employees of Advisors, to serve on Xtant's board of directors. This report shall not be deemed an admission that any such entity is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act or for any other purposes.
F4 See Exhibit 99.2.